Andrew Schutte is President and Chief Executive Officer of RepliCel and a member of its Board of Directors. He has spent his career in entrepreneurial businesses, building early-stage companies from the ground up. As CEO, he led RepliCel’s transition from a publicly traded company to a privately held one, and he oversees the Company’s strategy, operations and research and development programs. Mr. Schutte has been a shareholder of RepliCel since 2017 and joined its Board of Directors in 2018.